Utility transdermal delivery system antihypertensive therapy retrospective evaluation patient-level Medicaid data states fiscal utility clonidine oral formulation clonidine oral formulations antihypertensive agents first phase two-part study claims data Florida transdermal oral clonidine Multivariate regression analysis incremental impact variables health-care expenditures first year patients diagnosis hypertension variables age gender prior utilization medical services regimen complexity dosage formulation Patients transdermal clonidine significant equal increase prescription expenditures significant reductions use physician equal laboratory equal hospital equal services savings equal multi-drug regimens transdermal delivery system second phase study claims data South Carolina transdermal clonidine oral antihypertensive agents atenolol captopril clonidine diltiazem enalapril metoprolol prazosin terazosin Once regression analysis time incremental impact variables health-care expenditures first year post diagnosis age gender prior utilization medical services regimen complexity Medication Possession Ratio MPR index compliance data part study patients b.i.d oral antihypertensive agent significant reduction equal MPR significant increase health-care expenditures patients transdermal delivery system patients once-daily oral medications data previous findings impact complicated regimens compliance hypertensive patients two-part paper data phases study 